en
Scientific article
Open access
English

AMYPAD Diagnostic and Patient Management Study: Rationale and design

Publication date2018
Abstract

Reimbursement of amyloid-PET is lagging due to the lack of definitive evidence on its clinical utility and cost-effectiveness. The Amyloid Imaging to Prevent Alzheimer's Disease-Diagnostic and Patient Management Study (AMYPAD-DPMS) is designed to fill this gap.

Keywords
  • Amyloid-PET
  • Alzheimer's disease
  • Mild cognitive impairment
  • Subjective cognitive decline
  • Clinical validity
  • Cost-effectiveness
Citation (ISO format)
FRISONI, Giovanni, BARKHOF, Frederik, CANZONERI, Elisa. AMYPAD Diagnostic and Patient Management Study: Rationale and design. In: Alzheimer’s & Dementia, 2018. doi: 10.1016/j.jalz.2018.09.003
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal1552-5260
373views
262downloads

Technical informations

Creation01/04/2019 4:41:00 PM
First validation01/04/2019 4:41:00 PM
Update time03/15/2023 3:43:08 PM
Status update03/15/2023 3:43:08 PM
Last indexation05/03/2024 7:08:03 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack